OTC : BRCNF
$0.04 (3.03%)
| Source | Headline |
|---|---|
|
Is Burcon NutraScience (BRCNF) Stock Outpacing Its Consumer Staples Peers This Year?
Here is how Burcon NutraScience Corp (BRCNF) and Ryohin Keikaku Co. Ltd. (RYKKY) have performed compared to their sector so far this year. zacks.com - 2026-07-14 10:40:23 |
|
Burcon NutraScience Corporation (BU:CA) Q4 2026 Earnings Call Transcript
Burcon NutraScience Corporation (BU:CA) Q4 2026 Earnings Call Transcript seekingalpha.com - 2026-06-24 20:32:09 |
|
Burcon Announces Fiscal 2026 Results
Vancouver, British Columbia--(Newsfile Corp. - June 24, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, reported results for the fiscal year ended March 31, 2026. "Fiscal 2026 marked Burcon's transition from technology development to commercial execution," said Kip Underwood, Chief Executive Officer of Burcon. newsfilecorp.com - 2026-06-24 16:11:00 |
|
Burcon Announces Fiscal Year 2026 Conference Call and Presentation to be Held on June 24, 2026
Vancouver, British Columbia--(Newsfile Corp. - June 19, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, will hold an investor conference call and webcast on Wednesday, June 24, 2026 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal year ended March 31, 2026. newsfilecorp.com - 2026-06-19 08:00:00 |
|
Burcon Accelerates Growth & Achieves New Production Record
Advancing Burcon's commercialization journey through growing commercial traction and manufacturing scale Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based proteins, today announced continued commercial and operational momentum, highlighted by strong growth in sales compared to the previous quarter and the establishment of a new production record with its manufacturing partner, marking another milestone in Burcon's transition from technology development to commercial-scale ingredient sales. "Approximately 50% growth in sales compared to the previous quarter, combined with record production performance, reflects the continued transition of Burcon from technology development to commercial-scale ingredient sales," said Kip Underwood, Chief Executive Officer of Burcon. newsfilecorp.com - 2026-06-16 08:00:00 |
|
Burcon Announces Appointment of New Director
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (the "Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the appointment of Mr. Chris Bunio to the board of directors (the "Board") of Burcon. newsfilecorp.com - 2026-04-29 17:21:00 |
|
Burcon Closes Final Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million
Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the closing of the final tranche of its previously announced non-brokered private placement (see news releases of the Company dated January 2, 2026, January 9, 2026 and February 27, 2026) of convertible debentures (the "Convertible Debentures") for an aggregate principal amount of $6.9 million (the "Private Placement"). Under the final tranche, Burcon issued Convertible Debentures in the aggregate principal amount of $2.9 million. newsfilecorp.com - 2026-04-27 07:58:00 |
|
Burcon Achieves Record Production, Expands to More than 20 Buying Customers and Evaluates Additional Capacity Expansion
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based proteins, today announced recent operational and commercial milestones demonstrating accelerating momentum in its scale-up and commercialization strategy. Over the past several weeks, the Company achieved record production, increasing average daily output by approximately 40% as compared to the calendar Q1 average, which proves production capability needed to achieve 2026 goals. newsfilecorp.com - 2026-04-20 08:00:00 |